Navigation Links
UPDATE: China PharmaHub Corp. Introduces a 'Magic Bullet' Liver Cancer Therapy to China, Hong Kong, Taiwan, Macau, Singapore, Malaysia, and Bangladesh
Date:8/26/2010

therapy combats tumors in patients with hepatocellular carcinoma (HCC), commonly known as primary liver cancer, who cannot be treated with surgery, and are awaiting an organ transplant.

As the exclusive distributor in the Greater China Region, Singapore, Malaysia and Bangladesh of this new form of liver cancer treatment, PharmaHub believes that the therapy offers a solution to the problem of malignant liver cancer in Southeast Asia where approximately three-quarters of the cases of liver cancer worldwide are found. China, alone, has the highest number of liver cancer patients worldwide, approximately one-half of the world HCC population, with more than 350,000 new cases diagnosed each year, a number that is expected by Management to continue to rise in the coming years. As projected by IMS Health, China will become the world's third-largest pharmaceutical market by 2011, growing by more than 20% annually. Oncology is among the top five therapy classes in China, which recorded a staggering 27% compound annual growth rate ("CAGR") from 2005-2009 and is poised to achieve similar gains through 2015.

Richard Lui, CEO of PharmaHub stated, "We are thrilled with this opportunity to take a leadership role in introducing this type of radioembolization treatment for inoperable liver cancer in China and Southeast Asia. This therapy is a pioneering alternative to surgery, chemotherapy and other radiation therapies in current usage. Overall, the treatment can cause fewer and milder side effects than other current treatments and offers the convenience of outpatient therapy at a significantly lower price than the more conventional treatments."

"PharmaHub plans to immediately set up clinical studies in China to test wider applications of the medical technology, not only for liver but other cancers, then move to commercialization of the procedure in a cost-effective and reliable manner throughout China," stated Mr. Lui.   "We also foresee the potential medic
'/>"/>

SOURCE China PharmaHub Corp.
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2 3 4

Related medicine technology :

1. UPDATE: Nile Therapeutics Announces Positive Phase 1a Results of CD-NP, a Selective NPR-B Agonist in Clinical Development for the Treatment of Heart Failure
2. UPDATE: New Report by Pediatricians Finds Gaps in Preparing to Protect Kids From Pandemic Flu, Offers Recommendations
3. UPDATE: Nebivolol Lowers Blood Pressure in African Americans With Stage I-II Hypertension as Demonstrated in a Study Published in the Journal of Clinical Hypertension
4. UPDATE: Infant Primates Given Vaccines on U.S. Childrens Immunization Schedule Develop Behavioral Symptoms of Autism
5. ELADUR(TM) Development Update: DURECT Receives Orphan Drug Designation for Bupivacaine for Post-Herpetic Neuralgia
6. UPDATE: US Oncology Research Network Participates in Phase III Follow-up Study to BiPars Investigational Cancer Drug BSI-201
7. UPDATE: FDA Issues 22 Warning Letters to Web site Operators
8. Update: International HIV/AIDS Partnership Wins Two Awards for Supply Chain Excellence
9. HUYA Bioscience Intl Announces Clinical Trial Milestones in China for Promising New Anti-Arrhythmic Compound; Data Supports Desirable Safety Profile
10. HUYA Bioscience Intl Announces World-Class Clinical Advisory Team for New Anti-Arrhythmic Compound Sourced From China
11. HUYA Bioscience Intl Announces First Pre-IND Outcome for a Development Stage Compound Sourced From China - HBI-8000, Promising New Cancer Compound
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:8/29/2014)... Research and Markets has announced the addition ... report to their offering. Benefiting ... for medical expenses, the Chinese orthopedic instrument market demand ... CAGR of 19.2% during 2009-2013. Trauma products, spine products ... instruments in China , of which ...
(Date:8/29/2014)... DENVER , Aug. 29, 2014 Does your ... date, nearly 800 doctors have recommended marijuana to the over ... Amendment 20. But the majority of the other roughly 20,300+ ... still know very little about it – even though a ... adults say they have tried it. ...
(Date:8/29/2014)... August 29, 2014 According ... Product & Services (Equipment, Reagent, Primer, Probe, Custom ... PCR, QPCR, Gene Synthesis, NGS, DNA, RNAi) - ... global Oligonucleotide Synthesis Market is expected to reach ... 2014, growing at a CAGR of 9.8% from ...
Breaking Medicine Technology:China Orthopedic Instrument Industry Report, 2014-2017 2Medical Rules Marijuana Sales in Colorado But Most Doctors Still in the Dark 2Medical Rules Marijuana Sales in Colorado But Most Doctors Still in the Dark 3Medical Rules Marijuana Sales in Colorado But Most Doctors Still in the Dark 4Oligonucleotide Synthesis Market Worth $1,712.1 Million by 2019 2Oligonucleotide Synthesis Market Worth $1,712.1 Million by 2019 3Oligonucleotide Synthesis Market Worth $1,712.1 Million by 2019 4
... (Allscripts – NASDAQ: MDRX ) today announced its ... (Logo:   http://photos.prnewswire.com/prnh/20100901/CG58147LOGO ) Third ... million, compared to $198.6 million in the third quarter of ... of $368.8 million; non-GAAP revenue of $371.4 million, a 13 ...
...  Prescription copay coupon marketing programs, which lure insured consumers ... increase costs by $32 billion over the next decade, ... by the Pharmaceutical Care Management Association (PCMA). ... undermine efforts by employers, unions and state governments to ...
Cached Medicine Technology:Allscripts Reports Third Quarter 2011 Results 2Allscripts Reports Third Quarter 2011 Results 3Allscripts Reports Third Quarter 2011 Results 4Allscripts Reports Third Quarter 2011 Results 5Allscripts Reports Third Quarter 2011 Results 6Allscripts Reports Third Quarter 2011 Results 7Allscripts Reports Third Quarter 2011 Results 8Allscripts Reports Third Quarter 2011 Results 9Allscripts Reports Third Quarter 2011 Results 10Allscripts Reports Third Quarter 2011 Results 11Allscripts Reports Third Quarter 2011 Results 12Allscripts Reports Third Quarter 2011 Results 13Allscripts Reports Third Quarter 2011 Results 14Allscripts Reports Third Quarter 2011 Results 15Allscripts Reports Third Quarter 2011 Results 16Report: Brand Drug 'Copay Coupons' Raise Health Costs for Employers, Unions, and State Governments by $32 Billion 2
(Date:8/30/2014)... New York, New York (PRWEB) August 30, 2014 ... and other incretin mimetic claims continue to move forward ... a statement issued by AstraZeneca PLC on July 31, ... have been named in 409 product liability claims that ... cancer. Court documents indicate that many of these claims ...
(Date:8/30/2014)... 2014 Hastings and Hastings, a qualified ... throughout Arizona is pleased to report having saved a ... example among many cases where Hastings and Hastings has ... retain a greater portion of their settlement or recovery. ... a positive solution for Arizona car accident victims is ...
(Date:8/30/2014)... New York (PRWEB) August 30, 2014 ... development company in India, Profit By Outsourcing is ... Web Development services. The company gives emphasize on putting ... the complete product to clients. Their dedicated team of ... attaining ground-breaking results. They can handle even the critical ...
(Date:8/30/2014)... In today’s world, a good night’s sleep has ... sleep apnea (a medical problem where the airway collapses during ... of the rest they need to face their daily challenges. ... 20 million people in the United States alone have sleep ... and of those treated, many cannot tolerate their prescribed medical ...
(Date:8/30/2014)... (PRWEB) August 30, 2014 Removecomplaints.net, a ... management industry, has announced to offer guarantee of results ... to offer this guarantee because of its tremendous track ... 200 clients from all over the world and received ... good job. , On being asked about the ...
Breaking Medicine News(10 mins):Health News:Byetta Lawsuits Move Forward, as Bernstein Liebhard LLP Notes Settlements in More than 80 Cases 2Health News:Byetta Lawsuits Move Forward, as Bernstein Liebhard LLP Notes Settlements in More than 80 Cases 3Health News:Hastings and Hastings Is Pleased To Report Having Saved A Client $67,100 On A Settlement Of $610,000 2Health News:Profit By Outsourcing Offering Discount for Labor Day on all Web Development Services 2Health News:Snoring: Bad for Relationships, Bad for Health 2Health News:Snoring: Bad for Relationships, Bad for Health 3Health News:Removecomplaints.net Announces Guaranteed Complaints Removal Services 2
... associated with loss of blood supply to the brain , , ... type of depression in the elderly related to blood vessels ... have discovered why some patients with this condition fail to ... to be presented Wednesday during a news conference by researchers ...
... million, up 20% from first quarter ... - EPS of $0.38, up 36% from first quarter 2007, - Record new ... 2007, ... ...
... been made in reducing the harm of tobacco in ... ... Tomorrow marks the 10-year,anniversary of Minnesota,s historic settlement with the ... national headlines for,exposing millions of tobacco industry documents and for creating ...
... MELVILLE, N.Y., May 6 Today, Fougera, ... has received FDA approval to bring to ... (Rx) (Scalp,Solution). The generic formulation compares to ... ), Fougera,s Calcipotriene Topical Solution is ...
... Calif., May 6 Capitol Chiropractic,Buckle-Up Safe Day 2008 will ... noon and 3:30 p.m. to 6:30 p.m. at 9500 Micron ... great way to help prevent and/or reduce,car crash injuries to ... way of giving back to our community, through teaching simple ...
... Open Course in Celebrity Foursome, WASHINGTON, May 6 ... cancer survivor, John,Atkinson has won the Golf Digest U.S. ... over 56,000 entries., He will try to break ... the,pros for this year,s U.S. Open. Atkinson will compete ...
Cached Medicine News:Health News:Several Therapies Show Promise for Vascular Depression 2Health News:Several Therapies Show Promise for Vascular Depression 3Health News:Kendle Delivers Record Net Service Revenues and New Business Authorizations for First Quarter 2008 2Health News:Kendle Delivers Record Net Service Revenues and New Business Authorizations for First Quarter 2008 3Health News:Kendle Delivers Record Net Service Revenues and New Business Authorizations for First Quarter 2008 4Health News:Kendle Delivers Record Net Service Revenues and New Business Authorizations for First Quarter 2008 5Health News:Kendle Delivers Record Net Service Revenues and New Business Authorizations for First Quarter 2008 6Health News:Kendle Delivers Record Net Service Revenues and New Business Authorizations for First Quarter 2008 7Health News:ClearWay Minnesota(SM) Celebrates 10-Year Anniversary of Settlement 2Health News:Fougera First-to-Market With Calcipotriene Topical Solution 0.005% (Rx) (Scalp Solution) 2Health News:Sacramento Chiropractor Takes Aim at Reducing Car Accident Injuries 2Health News:Lung Cancer Alliance Advocate Wins Golf Digest Contest 2
... is a national reference laboratory and a ... development. ARUP offers an extensive test menu ... in clinical and anatomic pathology. Owned by ... include more than half of the nation's ...
... a national reference laboratory and a worldwide ... ARUP offers an extensive test menu of ... clinical and anatomic pathology. Owned by the ... more than half of the nation's university ...
... ARUP Laboratories is a national reference laboratory ... research and development. ARUP offers an extensive ... medical tests in clinical and anatomic pathology. ... Laboratories' clients include more than half of ...
... ARUP Laboratories is a national reference ... laboratory research and development. ARUP offers an ... unique medical tests in clinical and anatomic ... ARUP Laboratories' clients include more than half ...
Medicine Products: